Serving hundreds of leading biopharmaceutical companies globally:

Generated: February 15, 2019

DrugPatentWatch Database Preview

Regulatory Exclusivity: NEW INDICATION

« Back to Dashboard

Drugs with New Indication Regulatory Exclusivity

Click here to include patents covering these drugs in this list

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Exclusivity Expiration	Patented / Exclusive Use
Pharmacyclics Inc	IMBRUVICA	ibrutinib	CAPSULE;ORAL	205552-001	Nov 13, 2013		RX	Yes	Yes	➤ Sign Up	FOR THE TREATMENT OF PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA
Shire Dev Llc	VYVANSE	lisdexamfetamine dimesylate	TABLET, CHEWABLE;ORAL	208510-005	Jan 28, 2017		RX	Yes	No	➤ Sign Up	MODERATE TO SEVERE BINGE EATING DISORDER (BED)
Shire Dev Llc	VYVANSE	lisdexamfetamine dimesylate	TABLET, CHEWABLE;ORAL	208510-002	Jan 28, 2017		RX	Yes	No	➤ Sign Up	MODERATE TO SEVERE BINGE EATING DISORDER (BED)
Shire Development	VYVANSE	lisdexamfetamine dimesylate	CAPSULE;ORAL	021977-003	Feb 23, 2007		RX	Yes	Yes	➤ Sign Up	MODERATE TO SEVERE BINGE EATING DISORDER (BED)
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Exclusivity Expiration	Patented / Exclusive Use

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture

Federal Trade Commission

QuintilesIMS

Moodys

Cipla

Merck

Cerilliant

Johnson and Johnson

Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.